Politan Capital Management LP grew its holdings in shares of Azenta, Inc. (NASDAQ:AZTA – Free Report) by 0.0% in the 4th quarter, Holdings Channel reports. The fund owned 4,612,747 shares of the company’s stock after acquiring an additional 995 shares during the period. Azenta accounts for about 14.9% of Politan Capital Management LP’s investment portfolio, making the stock its 3rd biggest position. Politan Capital Management LP owned 0.10% of Azenta worth $230,637,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also modified their holdings of the company. Quantinno Capital Management LP raised its holdings in Azenta by 119.4% in the fourth quarter. Quantinno Capital Management LP now owns 18,709 shares of the company’s stock valued at $935,000 after acquiring an additional 10,183 shares in the last quarter. Nuveen Asset Management LLC grew its holdings in Azenta by 95.6% during the 4th quarter. Nuveen Asset Management LLC now owns 355,375 shares of the company’s stock worth $17,769,000 after acquiring an additional 173,699 shares in the last quarter. Millennium Management LLC increased its position in shares of Azenta by 19.8% in the 4th quarter. Millennium Management LLC now owns 108,175 shares of the company’s stock worth $5,409,000 after purchasing an additional 17,899 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Azenta by 13.8% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 50,507 shares of the company’s stock valued at $2,523,000 after purchasing an additional 6,139 shares in the last quarter. Finally, Gotham Asset Management LLC lifted its position in shares of Azenta by 388.2% during the fourth quarter. Gotham Asset Management LLC now owns 198,050 shares of the company’s stock worth $9,902,000 after purchasing an additional 157,483 shares during the last quarter. 99.08% of the stock is owned by hedge funds and other institutional investors.
Azenta Stock Down 3.4%
AZTA opened at $26.94 on Thursday. The company’s 50-day moving average price is $30.60 and its 200 day moving average price is $41.75. Azenta, Inc. has a fifty-two week low of $23.91 and a fifty-two week high of $63.58. The firm has a market cap of $1.23 billion, a price-to-earnings ratio of -9.04 and a beta of 1.64.
Analyst Upgrades and Downgrades
A number of research analysts have commented on AZTA shares. TD Cowen raised Azenta to a “hold” rating in a report on Thursday, February 27th. Evercore ISI raised their price objective on Azenta from $50.00 to $52.00 and gave the stock an “in-line” rating in a research note on Thursday, February 6th. Finally, Needham & Company LLC decreased their price objective on shares of Azenta from $59.00 to $40.00 and set a “buy” rating for the company in a report on Wednesday, May 7th.
View Our Latest Report on Azenta
About Azenta
Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.
Read More
- Five stocks we like better than Azenta
- What Investors Need to Know to Beat the Market
- Analysts Say Unilever Has the Leverage to Hit New Highs
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Homebuilders: Oversold, Undervalued, and Ready to Run?
- Are Penny Stocks a Good Fit for Your Portfolio?
- SMCI Stock Rally: 45% Gain in 2 Days Could Be Just the Start
Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA – Free Report).
Receive News & Ratings for Azenta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azenta and related companies with MarketBeat.com's FREE daily email newsletter.